ce
Continuing Education
New FDA Approved Drugs and Vaccines: 2023-2024
Author: Erin DiMuzio, PharmD This author has no conflict of interest to declare in conjunction with this continuing education activity. LEARNING OBJECTIVES: At the completion of this activity, the participant will be able to:
1. Describe the indication of a select number of new drugs and vaccines approved in 2023 and 2024. 2. Contrast key prescribing information such as the dosing, adverse events, storage, and drug interactions of these agents. 3. Utilize the provided information to successfully impact patient care in his or her pharmacy practice setting. Faculty: Erin DiMuzio, PharmD Contact Hour(s): 2.0 Activity Type: Knowledge-Based Home Study
Instructional Methods: Independent Self-Study + Post-Test Target Audience: Pharmacists and Pharmacy Technicians
Cost: NPTA Elite/CE+ Members: FREE; NPTA Insiders/Non-Members: $10 Disclosures: The CE faculty, reviewers and planning committee members have all reported no actual or potential conflict of interest in relation to this program. This program received no commercial support and has been peer-reviewed to ensure non-commercialization. ACPE UANs: 0384-0000-24-051-H01-P, 0384-0000-24-051-H01-T Release Date: 4/29/2024 Expiration Date: 4/29/2027 Completion of the post-test with minimum passing score of 70% is required to be awarded CPE contact hours. Participants are allowed a total of two attempts to pass the post-test. Please allow up to 10 business days for the credit to appear in your NABP CPE Monitor account.
NPTA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Disclaimers: The faculty has reported no actual or potential conflict of interest in relation to this program. This program received no commercial support and has been peer- reviewed to ensure non-commercialization.
support@pharmacytechnician.org 888-247-8700
CPhT CONNECT
www.cphtconnect.com 26
Made with FlippingBook - PDF hosting